batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. EHA 2025 – Arcellx still hopes safety will trump efficacy 16 June 2025 Pre-emptive US check for Keytruda's latest US use 13 June 2025 UroGen's rollercoaster sees Zusduri approved 13 June 2025 CureVac goes out with a whimper 12 June 2025 Bristol gets a new prostate cancer target 11 June 2025 More front-line Imdelltra details emerge 11 June 2025 MacroGenics goes for cash over royalties 10 June 2025 FDA checks checkpoint inhibitors 10 June 2025 Load More